In the 3rd part of a new SPM interview series, Charles Serhan, PhD, DSc answers the question: “Are there any recent findings or results in resolvins research that have surprised you?” Dr. Serhan discusses the recently discovered resolution role of specialized pro-resolving mediators (SPMs) in the adaptive immune response, including the regulation of B cell function and facilitating antibody production.
Charles Serhan, PhD, DSc is Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital and Professor of Anesthesia at Harvard Medical School.
From the 15th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, October 2017 in Puerto Vallarta, Mexico
